The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Smith Jeffrey Edward since 2008.
The trader's CIK number is 1363762.
At the time of the last reporting, Smith Jeffrey Edward was the CEO of Interpace Biosciences, Inc.. (stock ticker symbol IDXG).
Also see all insider trading activities at Interpace Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | PDII | 200,000 | $325,000 | 0 | $0 | 0 | $0 |
| 2009 | PDII | 2,500 | $13,125 | 0 | $0 | 0 | $0 |
| 2008 | PDII | 56,054 | $250,006 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-11-07 | PDII | Buy | 200,000 | 1.62 | 325,000 |
| 2009-08-21 | PDII | Buy | 2,500 | 5.25 | 13,125 |
| 2008-12-02 | PDII | Buy | 50,000 | 4.00 | 200,000 |
| 2008-06-26 | PDII | Buy | 6,054 | 8.26 | 50,006 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Jeffrey Edward (CEO of Interpace Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.